All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the MDS Hub spoke to Aziz Nazha, Cleveland Clinic, Cleveland, US. We asked: What are the challenges in diagnosing MDS?
What are the challenges in diagnosing MDS?
The past few years have seen the introduction of new terminology and techniques to improve the diagnosis of MDS and to address any challenges. Here, Aziz Nazha outlines how these are being put in place to better define patients.
Updated ESMO clinical practice guidelines for diagnosis, treatment, and follow-up of MDS
The European Society for Medical Oncology (ESMO) Guidelines Committee issued an update of their Clinical Practice Guidelines for myelodysplastic syndromes (MDS)...
The spectrum of clonal hematopoiesis
Clonal hematopoiesis (CH) describes the growth of a sub-population of blood cells that have at least one somatic mutation, leading to a greater risk of hematological malignancy and cardiovascular disease, and an...
Subscribe to get the best content related to MDS delivered to your inbox